KDIGO Individual Optimization of Management of CKD Patients with Diabetes and CVD Comorbidities
freecme000
Published on Feb 18, 2022
VIDEO EMBED ORIGINAL SOURCE - KDIGO
https://www.youtube.com/c/KDIGO/featured
Join KDIGO in a discussion about individual optimization of management of CKD patients with diabetes and CVD comorbidities. Prof. Christoph Wanner and a multi-disciplinary panel of international experts explore new cardioâ€kidney protection therapies, such as SGLT2is and the glucagon-like receptor-1 agonists, and highlight why the relationship among cardiology, nephrology, and metabolic medicine is more important than ever.
This session was presented at the ISN World Congress of Nephrology 2021 - © International Society of Nephrology 2021. Supported by Boehringer Ingelheim Lilly.
Category
- Your Subscription
freecme000 -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
29:08
KDIGO Clinical Practice Guideline on Diabetes Management in CKD
34 views 1117 days ago -
35:15
Management of Hyperkalemia in Patients With Hemodialysis-Dependent CKD
35 views 1322 days ago -
25:08
HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
34 views 1117 days ago -
56:07
KDIGO Optimal Anemia Management in CKD: A New Paradigm in Treatment?
30 views 1117 days ago